Cancer vaccines: shared tumor antigens return to the spotlight
Signal Transduct Target Ther
.
2020 Oct 30;5(1):251.
doi: 10.1038/s41392-020-00364-8.
Authors
Lijin Li
1
,
S Peter Goedegebuure
1
2
,
William Gillanders
3
4
Affiliations
1
Department of Surgery, Washington University School of Medicine, St Louis, MO, USA.
2
The Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St Louis, MO, USA.
3
Department of Surgery, Washington University School of Medicine, St Louis, MO, USA. gillandersw@wustl.edu.
4
The Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St Louis, MO, USA. gillandersw@wustl.edu.
PMID:
33127890
PMCID:
PMC7599325
DOI:
10.1038/s41392-020-00364-8
No abstract available
Publication types
Comment
MeSH terms
Antigens, Neoplasm
Cancer Vaccines*
Humans
Immunologic Tests
Melanoma*
RNA
Substances
Antigens, Neoplasm
Cancer Vaccines
RNA